Research Article

Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines

Volume: 2 Number: 1 May 3, 2024
EN

Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines

Abstract

Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines Karpuz Çekirdeği Ekstrelerinin Akciğer ve Meme Kanseri Hücre Hatlarına Karşı Antikanser Potansiyeli Running Title: Anticancer Potential of Watermelon Seed Abstract Objective: The aim of the study is to evaluate the anticancer potential of watermelon seed extracts against lung and breast cancer cell lines. Methods: A549 lung cancer and MCF-7 breast cancer cell lines were used. The cells were treated with doses ranging from 0.1 to 1000 µg/mL of KI and KD extracts from watermelon seeds, starting when the cell density reached 80%. Viability was assessed using the MTT assay. Results: For the A549 lung cell line, the KI extract demonstrated significant anticancer activity at doses of 10, 100, and 1000 µg/mL, with the 1000 µg/mL dose being the most effective against lung cancer cells. Similarly, the KD extract showed efficacy across all doses tested, with the seed peel being effective at lower doses compared to the seed. In the MCF-7 breast cell line, both KI and KD extracts exhibited dose-dependent anticancer effects, with significant reductions in viability observed at all doses compared to the control group. Conclusion: Interestingly, the seed and seed shell showed selective effectiveness against breast and lung cancer, indicating a dose-dependent and selective anticancer effect. Overall, these findings suggest the potential of watermelon seed extracts as promising anticancer agents with selective efficacy against different cancer types. Keywords: Watermelon, anticancer, A549 lung cancer cell, MCF-7 breast cancer cell ÖZ Amaç: Çalışmanın amacı, karpuz çekirdeği ekstrelerinin akciğer ve meme kanseri hücre hatlarına karşı antikanser potansiyelini değerlendirmektir. Yöntemler: A549 akciğer kanseri ve MCF-7 meme kanseri hücre hatları kullanılmıştır. Hücreler, yoğunlukları %80'e ulaştığında, karpuz çekirdeğinden hazırlanan KI ve KD ekstreleri ile 0.1 ila 1000 µg/mL doz aralığında muamele edilmiştir. Canlılık, MTT testi kullanılarak değerlendirilmiştir. Bulgular: A549 akciğer hücre hattı için KI ekstresi, 10, 100 ve 1000 µg/mL dozlarında önemli antikanser aktivite göstermiş, 1000 µg/mL dozu akciğer kanseri hücrelerine karşı en etkili olarak bulunmuştur. Benzer şekilde, KD ekstresi, test edilen tüm dozlarda etkili olmuş ve tohum kabuğunun, tohuma göre daha düşük dozlarda etkili olduğu görülmüştür. MCF-7 meme hücre hattında, hem KI hem de KD ekstreleri doza bağlı antikanser etki sergilemiş ve kontrol grubuna kıyasla tüm dozlarda önemli düzeyde canlılık azalması gözlenmiştir. Sonuç: Karpuz çekirdeği ve kabuğu meme ve akciğer kanserine karşı seçici etkinlik göstermiş, bu da doza bağlı ve seçici bir antikanser etkiyi işaret etmektedir. Genel olarak, bu bulgular, karpuz çekirdeği ekstrelerinin farklı kanser türlerine karşı seçici etkili ve umut vaat edici antikanser ajanlar olarak potansiyelini göstermektedir. Anahtar kelimeler: Karpuz, antikanser, A549 akciğer kanseri hücre, MCF-7 meme kanseri hücre

Keywords

Project Number

1689B012338882

References

  1. Arı, M., Öğüt, S., Kaçar Döğer, F. 2017. Kanserin önlenmesinde antioksidanların rolü, 1(2), 67-74. Aybek, H., Ağca, C. A., Çiftci, M. 2020. Investigation of cytotoxic and apoptotic effects of 5-fluorouracil (5-FU) and C60 nanoparticle on breast cancer (MCF-7) cell line, Journal of Molecular Biology and Genetics, 9(2), 35-41.
  2. Aydın, R.Ö. and Köseoğlu, S.Z.A. 2022. Investigation of the relationship between purple pigmented fruits and vegetables and cancer, European Journal of Science and Technology, 41, 485-491.
  3. Baser, K.H.C. 2022. Karpuz (Citrullus lanatus [Thunb.] Matsum. & Nakai), Bağbahçe, 101, 1-8.
  4. Di Sano, C., Lazzara, V., Durante, M., DAnna, C., Bonura, A., Dino, P., Uasuf, C.G., Pace, E., Lenucci, M.S., Bruno, A. 2022. The protective anticancer effect of natural lycopene supercritical CO2 watermelon extracts in adenocarcinoma lung cancer cells. Antioxidants, 11, 1150.
  5. Dyshlovoy, S.A. & Honecker, F. 2020. Marine compounds and cancer: Updates 2020, Mar Drugs, 18(12), 643. Hanahan, D., & Weinberg, R. A. 2000. The hallmarks of cancer. Cell, 100(1), 57–70. https://doi.org/10.1016/s0092-8674(00)81683-9.
  6. Itoh, T., Ono, A., Kawaguchi, K., Teraoka, S., Harada, M., Sumi, K., Ando, M., Tsukamasa, Y., Ninomiya, M., Koketsu, M., Hashizume, T. 2018. Phytol isolated from watermelon (Citrullus lanatus) sprouts induces cell death in human T-lymphoid cell line Jurkat cells via S-phase cell cycle arrest. Food and Chemical Toxicology, 115, 425-435.
  7. Mustafa, Y.F., Ismael, R.N. & Jebir, R.M. 2024. Natural coumarins from two cultivars of watermelon seeds as biosafe anticancer agents, an algorithm for their isolation and evaluation. Journal of Molecular Structure, 1295, 136644.
  8. Ohshima, K., & Morii, E. 2021. Metabolic reprogramming of cancer cells during tumor progression and metastasis. metabolites, 11(1), 28. https://doi.org/10.3390/metabo11010028.

Details

Primary Language

English

Subjects

Pharmacognosy, Medical Pharmacology

Journal Section

Research Article

Publication Date

May 3, 2024

Submission Date

April 25, 2024

Acceptance Date

May 2, 2024

Published in Issue

Year 2024 Volume: 2 Number: 1

APA
Yesilyurt, F., Özbek, H., Hacımüftüoğlu, M. E., Coşkun, A. N., Dumlu, A., & Coşkun, O. (2024). Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines. Recent Trends in Pharmacology, 2(1), 21-26. https://doi.org/10.62425/rtpharma.1473183
AMA
1.Yesilyurt F, Özbek H, Hacımüftüoğlu ME, Coşkun AN, Dumlu A, Coşkun O. Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines. Recent Trends in Pharmacology. 2024;2(1):21-26. doi:10.62425/rtpharma.1473183
Chicago
Yesilyurt, Fatma, Hilal Özbek, Mustafa Emir Hacımüftüoğlu, Ayşe Neva Coşkun, Azranur Dumlu, and Osman Coşkun. 2024. “Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines”. Recent Trends in Pharmacology 2 (1): 21-26. https://doi.org/10.62425/rtpharma.1473183.
EndNote
Yesilyurt F, Özbek H, Hacımüftüoğlu ME, Coşkun AN, Dumlu A, Coşkun O (May 1, 2024) Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines. Recent Trends in Pharmacology 2 1 21–26.
IEEE
[1]F. Yesilyurt, H. Özbek, M. E. Hacımüftüoğlu, A. N. Coşkun, A. Dumlu, and O. Coşkun, “Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines”, Recent Trends in Pharmacology, vol. 2, no. 1, pp. 21–26, May 2024, doi: 10.62425/rtpharma.1473183.
ISNAD
Yesilyurt, Fatma - Özbek, Hilal - Hacımüftüoğlu, Mustafa Emir - Coşkun, Ayşe Neva - Dumlu, Azranur - Coşkun, Osman. “Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines”. Recent Trends in Pharmacology 2/1 (May 1, 2024): 21-26. https://doi.org/10.62425/rtpharma.1473183.
JAMA
1.Yesilyurt F, Özbek H, Hacımüftüoğlu ME, Coşkun AN, Dumlu A, Coşkun O. Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines. Recent Trends in Pharmacology. 2024;2:21–26.
MLA
Yesilyurt, Fatma, et al. “Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines”. Recent Trends in Pharmacology, vol. 2, no. 1, May 2024, pp. 21-26, doi:10.62425/rtpharma.1473183.
Vancouver
1.Fatma Yesilyurt, Hilal Özbek, Mustafa Emir Hacımüftüoğlu, Ayşe Neva Coşkun, Azranur Dumlu, Osman Coşkun. Anticancer Potential of Watermelon Seed Extracts Against Lung and Breast Cancer Cell Lines. Recent Trends in Pharmacology. 2024 May 1;2(1):21-6. doi:10.62425/rtpharma.1473183

Cited By